Latest Beta secretase Stories
CoMentis, Inc. and Astellas Pharma, Inc. announced today that the companies will present six abstracts related to CTS21166 (ASP1702), a beta-secretase inhibitor for the treatment of Alzheimer's disease, at the 2008 International Conference on Alzheimer's Disease (ICAD) in Chicago, July 26-31.
By Anonymous Study details new molecular approach to preventing Alzheimer's. The April 24 Washington Post reported that German researchers have developed a new approach to the possible prevention of the molecular "debris" that is associated with the development of Alzheimer's disease.
German scientists say a new drug designed to attach itself to cells reversed signs of Alzheimer's disease when injected into the brains of mice and it could give hope to developing a new treatment for the condition in humans.
In mice, that had been genetically engineered to develop Alzheimer's disease, scientists were able to reverse the rodents' memory loss by reducing the amount of an enzyme that is crucial for the development of Alzheimer's disease.
The route to a treatment for Alzheimer's disease may have become more straightforward with the discovery that a key enzyme known to have a major role in this disease is in fact part of a family of enzymes. Only some family members play a role in the progression of this brain-wasting illness, new research at the University of Toronto has found.
- A volcanic mudflow.